No Cover Image

Journal article 1112 views 153 downloads

Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits

Ahmed Salem, Steve Bain Orcid Logo, Daniel Obaid Orcid Logo

Atherosclerosis, Volume: 352, Pages: 83 - 84

Swansea University Authors: Ahmed Salem, Steve Bain Orcid Logo, Daniel Obaid Orcid Logo

  • Salem2022.pdf

    PDF | Accepted Manuscript

    ©2022 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)

    Download (150.1KB)

Check full text

DOI (Published version): 10.1016/j.atherosclerosis.2022.05.010

Published in: Atherosclerosis
ISSN: 0021-9150
Published: Elsevier BV 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa60290
first_indexed 2022-06-22T08:40:55Z
last_indexed 2024-11-14T12:17:04Z
id cronfa60290
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2024-07-10T12:50:37.3276419</datestamp><bib-version>v2</bib-version><id>60290</id><entry>2022-06-22</entry><title>Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits</title><swanseaauthors><author><sid>fe8d190b0388826e229257c2d3d89d22</sid><firstname>Ahmed</firstname><surname>Salem</surname><name>Ahmed Salem</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>1cb4b49224d4f3f2b546ed0f39e13ea8</sid><ORCID>0000-0002-3891-1403</ORCID><firstname>Daniel</firstname><surname>Obaid</surname><name>Daniel Obaid</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-06-22</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Atherosclerosis</journal><volume>352</volume><journalNumber/><paginationStart>83</paginationStart><paginationEnd>84</paginationEnd><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0021-9150</issnPrint><issnElectronic/><keywords>Diabetes mellitus; Cardiovascular disease; Anti-inflammatory agent; Glucagon-like peptide-1 receptor agonists (GLP-1RA)</keywords><publishedDay>1</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-07-01</publishedDate><doi>10.1016/j.atherosclerosis.2022.05.010</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Not Required</apcterm><funders/><projectreference/><lastEdited>2024-07-10T12:50:37.3276419</lastEdited><Created>2022-06-22T09:37:49.1358544</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Ahmed</firstname><surname>Salem</surname><order>1</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>2</order></author><author><firstname>Daniel</firstname><surname>Obaid</surname><orcid>0000-0002-3891-1403</orcid><order>3</order></author></authors><documents><document><filename>60290__24350__a506b39376f8439e9ad4d691f0b145bc.pdf</filename><originalFilename>Salem2022.pdf</originalFilename><uploaded>2022-06-22T09:38:35.4610495</uploaded><type>Output</type><contentLength>153701</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2023-05-18T00:00:00.0000000</embargoDate><documentNotes>&#xA9;2022 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc-nd/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2024-07-10T12:50:37.3276419 v2 60290 2022-06-22 Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits fe8d190b0388826e229257c2d3d89d22 Ahmed Salem Ahmed Salem true false 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 1cb4b49224d4f3f2b546ed0f39e13ea8 0000-0002-3891-1403 Daniel Obaid Daniel Obaid true false 2022-06-22 MEDS Journal Article Atherosclerosis 352 83 84 Elsevier BV 0021-9150 Diabetes mellitus; Cardiovascular disease; Anti-inflammatory agent; Glucagon-like peptide-1 receptor agonists (GLP-1RA) 1 7 2022 2022-07-01 10.1016/j.atherosclerosis.2022.05.010 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Not Required 2024-07-10T12:50:37.3276419 2022-06-22T09:37:49.1358544 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Ahmed Salem 1 Steve Bain 0000-0001-8519-4964 2 Daniel Obaid 0000-0002-3891-1403 3 60290__24350__a506b39376f8439e9ad4d691f0b145bc.pdf Salem2022.pdf 2022-06-22T09:38:35.4610495 Output 153701 application/pdf Accepted Manuscript true 2023-05-18T00:00:00.0000000 ©2022 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND) true eng https://creativecommons.org/licenses/by-nc-nd/4.0/
title Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits
spellingShingle Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits
Ahmed Salem
Steve Bain
Daniel Obaid
title_short Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits
title_full Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits
title_fullStr Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits
title_full_unstemmed Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits
title_sort Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits
author_id_str_mv fe8d190b0388826e229257c2d3d89d22
5399f4c6e6a70f3608a084ddb938511a
1cb4b49224d4f3f2b546ed0f39e13ea8
author_id_fullname_str_mv fe8d190b0388826e229257c2d3d89d22_***_Ahmed Salem
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
1cb4b49224d4f3f2b546ed0f39e13ea8_***_Daniel Obaid
author Ahmed Salem
Steve Bain
Daniel Obaid
author2 Ahmed Salem
Steve Bain
Daniel Obaid
format Journal article
container_title Atherosclerosis
container_volume 352
container_start_page 83
publishDate 2022
institution Swansea University
issn 0021-9150
doi_str_mv 10.1016/j.atherosclerosis.2022.05.010
publisher Elsevier BV
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2022-07-01T06:33:17Z
_version_ 1850739573251899392
score 11.08895

Similar Items